search
Back to results

A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol (tACS-MI)

Primary Purpose

Alcohol Use Disorder

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
High-density transcranial alternating current stimulation
Sham stimulation
Motivational interviewing
Sponsored by
The Mind Research Network
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Alcohol Use Disorder focused on measuring Alcohol Use Disorder, Motivational Interviewing, Transcranial Electrical Stimulation, Alcohol Drinking

Eligibility Criteria

21 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria:

  • Self-identify as having problem drinking
  • Right-handed
  • Age 21-60 years
  • AUDIT score indicating risky drinking

Exclusion criteria:

  • Left-handed or ambidextrous
  • Currently engaged in treatment for alcohol use disorder
  • Receiving treatment for alcohol use disorder within the prior 12 months
  • History of brain injury or neurological diagnosis
  • Evidence of current psychosis
  • Past-year substance use disorder other than alcohol, marijuana, or nicotine
  • Current or history of severe alcohol withdrawal
  • MRI/tACS contraindications including pregnancy
  • Impaired hearing (psychotherapy using American Sign Language is not possible within the scope of the proposed study)
  • Insufficient corrected visual acuity to complete the assessment instruments
  • Unable to read/speak English fluently
  • Unable to provide valid informed consent

Sites / Locations

  • The Mind Research NetworkRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Sham Comparator

Active Comparator

Arm Label

MI with tACS

MI with sham

MI-only

Arm Description

Motivational interviewing with concurrent active stimulation

Motivational interviewing with concurrent sham stimulation

Motivational interviewing only, delayed treatment control

Outcomes

Primary Outcome Measures

Heavy drinking days
Number of heavy drinking days in the prior 30 days

Secondary Outcome Measures

Drinks per drinking day
Number of drinks per drink day in the prior 30 days
Percent days abstinent
Percent days abstinent in the prior 30 days

Full Information

First Posted
February 22, 2021
Last Updated
March 7, 2023
Sponsor
The Mind Research Network
Collaborators
National Institute of General Medical Sciences (NIGMS)
search

1. Study Identification

Unique Protocol Identification Number
NCT04770025
Brief Title
A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
Acronym
tACS-MI
Official Title
Transcranial Alternating Current Stimulation to Boost the Efficacy of Motivational Interviewing
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2020 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
February 28, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Mind Research Network
Collaborators
National Institute of General Medical Sciences (NIGMS)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this small (n=75) proof-of-concept randomized clinical trial is to test the effects of transcranial alternating current stimulation (tACS) during motivational interviewing (MI) sessions with participants who drink at above the low-risk level. Participants will be randomized to receive either MI with active stimulation, MI with sham stimulation, or a delayed treatment group that receives MI with no stimulation. Measures will include brain imaging, alcohol use, cannabis use, risk-taking behavior, emotions, and others. Participants who are randomized to the delayed-treatment group will not receive brain imaging.
Detailed Description
This proof-of-concept randomized clinical trial will recruit n=75 people with problematic levels of drinking who are considering treatment for their alcohol use. These participants will be randomized to one of three conditions: a condition that applies active tACS during an MI session (MI+tACS), a condition that applies sham stimulation during an MI session (MI+sham), or a waitlist control condition (MI-only). Only participants the MI+tACS and MI+sham conditions will be included in the brain imaging portion of the study. One month after their intervention session, all participants will report their use of alcohol in the prior 30 days via an online assessment battery. This will allow us to test the effects of tACS on within-session client speech and outcomes. Participants will have magnetoencephalography (MEG) scans including rest and an alcohol cue task to measure the acute effects of brain stimulation. Participants will also have MRI scans including structure and rest. The Motivational Interviewing Skill Code (MISC 2.5) and the CASAA Application for Coding Treatment Interactions (CACTI) will be used to assess counselor and participant speech in the recorded MI sessions and to ensure that sessions comply with the principles of MI.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcohol Use Disorder
Keywords
Alcohol Use Disorder, Motivational Interviewing, Transcranial Electrical Stimulation, Alcohol Drinking

7. Study Design

Primary Purpose
Other
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
Double-blind proof-of-concept randomized clinical trial
Masking
ParticipantCare Provider
Masking Description
Double (Participant, Providers/Research Assistants)
Allocation
Randomized
Enrollment
75 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
MI with tACS
Arm Type
Experimental
Arm Description
Motivational interviewing with concurrent active stimulation
Arm Title
MI with sham
Arm Type
Sham Comparator
Arm Description
Motivational interviewing with concurrent sham stimulation
Arm Title
MI-only
Arm Type
Active Comparator
Arm Description
Motivational interviewing only, delayed treatment control
Intervention Type
Device
Intervention Name(s)
High-density transcranial alternating current stimulation
Intervention Description
High-density electrode configuration with transcranial alternating current stimulation in the beta (15-40Hz) frequency range
Intervention Type
Device
Intervention Name(s)
Sham stimulation
Intervention Description
High-density electrode configuration with sham stimulation
Intervention Type
Behavioral
Intervention Name(s)
Motivational interviewing
Intervention Description
Motivational interviewing session focused on alcohol use, approximately 30 minutes in length
Primary Outcome Measure Information:
Title
Heavy drinking days
Description
Number of heavy drinking days in the prior 30 days
Time Frame
One month
Secondary Outcome Measure Information:
Title
Drinks per drinking day
Description
Number of drinks per drink day in the prior 30 days
Time Frame
One month
Title
Percent days abstinent
Description
Percent days abstinent in the prior 30 days
Time Frame
One month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria: Self-identify as having problem drinking Right-handed Age 21-60 years AUDIT score indicating risky drinking Exclusion criteria: Left-handed or ambidextrous Currently engaged in treatment for alcohol use disorder Receiving treatment for alcohol use disorder within the prior 12 months History of brain injury or neurological diagnosis Evidence of current psychosis Past-year substance use disorder other than alcohol, marijuana, or nicotine Current or history of severe alcohol withdrawal MRI/tACS contraindications including pregnancy Impaired hearing (psychotherapy using American Sign Language is not possible within the scope of the proposed study) Insufficient corrected visual acuity to complete the assessment instruments Unable to read/speak English fluently Unable to provide valid informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jon M Houck, PhD
Phone
(505) 925-2372
Email
brainstim@mrn.org
Facility Information:
Facility Name
The Mind Research Network
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87106
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jon M Houck, PhD
Phone
505-925-2372
Email
brainstim@mrn.org

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie results reported in a peer-reviewed publication, after deidentification (text, tables, figures, and appendices). Session audio recordings will not be shared.
IPD Sharing Time Frame
Beginning 3 months and ending 5 years following article publication.
IPD Sharing Access Criteria
Researchers who provide a methodologically sound proposal will have access to the data. A data use agreement will be required, signed by the requesting investigator and their Authorized Organization Representative (AOR)/Signing Official (SO)

Learn more about this trial

A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol

We'll reach out to this number within 24 hrs